Ticker

The critical minerals corner is splitting this morning between a company-specific bid in antimony and a rare earth basket that's drifting lower. That's the tell in what looks like an isolated single-name bounce.

United States Antimony is rated Buy, with a $10-11 target, as the market overreacts to weak antimony prices and trailing revenue. Q2 volumes rose 26% YoY despite a 52% drop in realized antimony prices, indicating operational strength masked by commodity headwinds. A $245M government contract is ramping up, with revenue conversion just beginning and significant upside potential as deliveries accelerate.

Shares of United States Antimony Co. (NYSE: UAMY - Get Free Report) traded down 5.8% during trading on Friday. The company traded as low as $4.83 and last traded at $4.86. 2,003,651 shares were traded during trading, a decline of 82% from the average session volume of 11,226,925 shares. The stock had previously closed at

Critical Metals is surging nearly 20% while its rare earth peers sit flat or slide lower, and no company announcement explains the gap. One unverified catalyst keeps surfacing in trader circles, and it has nothing to do with the ground under Greenland.

"The Critical Minerals and ZEO Company" ~ Antimony, Gold, Tungsten, and Zeolite ~ DALLAS, TX / ACCESS Newswire / August 25, 2026 / United States Antimony Corporation ("USAC," "US Antimony," or the "Company"), (NYSE:UAMY)(NYSE Texas:UAMY), a leading producer and processor of antimony, zeolite, and other critical minerals, and the only fully integrated antimony company in the world outside of China and Russia, is…